These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 36563642)

  • 41. Bioinformatics and experimental approach identify lipocalin 2 as a diagnostic and prognostic indicator for lung adenocarcinoma.
    Li A; Zhang K; Zhou J; Li M; Fan M; Gao H; Ma R; Gao L; Chen M
    Int J Biol Macromol; 2024 Jun; 272(Pt 2):132797. PubMed ID: 38848833
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Integrated analyzes identify CCT3 as a modulator to shape immunosuppressive tumor microenvironment in lung adenocarcinoma.
    Huang J; Hu B; Yang Y; Liu H; Fan X; Zhou J; Chen L
    BMC Cancer; 2023 Mar; 23(1):241. PubMed ID: 36918801
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.
    Yu L; Cao S; Li J; Han B; Zhong H; Zhong R
    Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overexpression of BCCIP predicts an unfavorable prognosis and promotes the proliferation and migration of lung adenocarcinoma.
    Shi J; Lv X; Li W; Ming Z; Zeng L; Yuan J; Chen Y; Liu B; Yang S
    Thorac Cancer; 2021 Sep; 12(17):2324-2338. PubMed ID: 34297484
    [TBL] [Abstract][Full Text] [Related]  

  • 45. STARD12/14 are diagnostic and prognostic biomarkers of lung adenocarcinoma associated with epigenetic regulation, immune infiltration and ferroptosis.
    Zhang WD; Hu DM; Shi ZE; Wang QX; Zhang MY; Liu JY; Ji XL; Qu YQ
    Int J Med Sci; 2023; 20(11):1427-1447. PubMed ID: 37790851
    [No Abstract]   [Full Text] [Related]  

  • 46. Correlation between prognostic indicator AHNAK2 and immune infiltrates in lung adenocarcinoma.
    Zheng M; Liu J; Bian T; Liu L; Sun H; Zhou H; Zhao C; Yang Z; Shi J; Liu Y
    Int Immunopharmacol; 2021 Jan; 90():107134. PubMed ID: 33168407
    [TBL] [Abstract][Full Text] [Related]  

  • 47. GRAP2 is a prognostic biomarker and correlated with immune infiltration in lung adenocarcinoma.
    Song S; Deng X; Jiang S; Tian C; Han J; Chai J; Li N; Yan Y; Luo Z
    J Clin Lab Anal; 2022 Nov; 36(11):e24662. PubMed ID: 36181310
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Mutational Signatures Analysis of Micropapillary Components and Exploration of ZNF469 Gene in Early-stage Lung Adenocarcinoma with Ground-glass Opacities].
    Xu Y; Sun Q; Wang S; Zhu H; Dong G; Meng F; Xia Z; You J; Kong X; Wu J; Chen P; Yuan F; Yu X; Ji J; Li Z; Zhu P; Sun Y; Liu T; Yin R; Xu L
    Zhongguo Fei Ai Za Zhi; 2024 Jan; 26(12):889-900. PubMed ID: 38151328
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NME6 as a potential biomarker and therapeutic target involved in immune infiltration for lung adenocarcinoma.
    Luo L; Li Y; Zhang L; Yang L
    Technol Health Care; 2024; 32(4):2277-2291. PubMed ID: 38517815
    [TBL] [Abstract][Full Text] [Related]  

  • 50. BOLA3 is a prognostic-related biomarker and correlated with immune infiltrates in lung adenocarcinoma.
    Wang XF; Lei W; Liu CM; Yang J; Zhu YH
    Int Immunopharmacol; 2022 Jun; 107():108652. PubMed ID: 35286914
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elevated ADAR expression is significantly linked to shorter overall survival and immune infiltration in patients with lung adenocarcinoma.
    Hu S; Wang F; Yang J; Xu X
    Math Biosci Eng; 2023 Sep; 20(10):18063-18082. PubMed ID: 38052548
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic and immunological potential of PPM1G in lung adenocarcinoma.
    Yin R; Qu L; Wang Z; Tang J; Gu H; Wang X; Yang D; Du P; Dong M
    Mol Med Rep; 2023 Aug; 28(2):. PubMed ID: 37387407
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integrated profiling of endoplasmic reticulum stress-related DERL3 in the prognostic and immune features of lung adenocarcinoma.
    Lin L; Lin G; Lin H; Chen L; Chen X; Lin Q; Xu Y; Zeng Y
    Front Immunol; 2022; 13():906420. PubMed ID: 36275646
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Zc3h12d, a Novel of Hypomethylated and Immune-Related for Prognostic Marker of Lung Adenocarcinoma.
    Yang B; Ji LL; Xu HL; Li XP; Zhou HG; Xiao T; Li XH; Gao ZY; Li JZ; Zhang WD; Wang GS; Li MJ
    J Inflamm Res; 2021; 14():2389-2401. PubMed ID: 34163207
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Junctional Adhesion Molecule-Like Protein (JAML) Is Correlated with Prognosis and Immune Infiltrates in Lung Adenocarcinoma.
    Fang L; Yu W; Yu G; Zhong F; Ye B
    Med Sci Monit; 2022 Jan; 28():e933503. PubMed ID: 35034089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of ALG3 as a potential prognostic biomarker in lung adenocarcinoma.
    Yuan Y; Xie B; Guo D; Liu C; Jiang G; Lai G; Zhang Y; Hu X; Wu Z; Zheng R; Huang L
    Heliyon; 2023 Jul; 9(7):e18065. PubMed ID: 37539167
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Upregulation of GNPNAT1 Predicts Poor Prognosis and Correlates With Immune Infiltration in Lung Adenocarcinoma.
    Liu W; Jiang K; Wang J; Mei T; Zhao M; Huang D
    Front Mol Biosci; 2021; 8():605754. PubMed ID: 33842535
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ZC3H12D is a prognostic biomarker associated with immune cell infiltration in lung adenocarcinoma.
    Gong W; Dai W; Wei H; Chen Y; Zheng Z
    Transl Cancer Res; 2020 Oct; 9(10):6128-6142. PubMed ID: 35117224
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nuclear protein NOP2 serves as a poor-prognosis predictor of LUAD and aggravates the malignancy of lung adenocarcinoma cells.
    Qin W; Fei G; Zhou Q; Li Z; Li W; Wei P
    Funct Integr Genomics; 2024 Mar; 24(2):58. PubMed ID: 38489049
    [TBL] [Abstract][Full Text] [Related]  

  • 60. BTN3A2 Expression Is Connected With Favorable Prognosis and High Infiltrating Immune in Lung Adenocarcinoma.
    Lin Y; Zhou H; Li S
    Front Genet; 2022; 13():848476. PubMed ID: 35873496
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.